FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 193 filers reported holding FIBROGEN INC in Q4 2017. The put-call ratio across all filers is 2.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,779,000 | +216.5% | 28,415 | +139.8% | 0.68% | +110.5% |
| Q4 2017 | $562,000 | +67.3% | 11,850 | +89.9% | 0.32% | +53.8% |
| Q3 2017 | $336,000 | -69.1% | 6,240 | -82.5% | 0.21% | -81.6% |
| Q4 2015 | $1,087,000 | +42.5% | 35,668 | +2.5% | 1.14% | +66.2% |
| Q3 2015 | $763,000 | – | 34,805 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
| ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
| Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
| 5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
| BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
| Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
| Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
| Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
| Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |